CyanConnode Holdings plc (CYAN) · 2026-09-15
Cancellaton - CyanConnode Holdings plc
CyanConnode Holdings' ordinary shares have been cancelled from trading on AIM at the company's request, removing their AIM listing with immediate effect.
UK company announcements filtered and explained for private investors.
CyanConnode Holdings plc (CYAN) · 2026-09-15
CyanConnode Holdings' ordinary shares have been cancelled from trading on AIM at the company's request, removing their AIM listing with immediate effect.
Caledonian Holdings PLC (CHP) · 2026-09-15
Caledonian Holdings has raised gross proceeds of approximately £644,147 through its share issuance facility, issuing 41,303,724 shares at an average 1.55954 pence each. It plans a further block admission of up to 44,063,447 shares, equal to approximately 20% of enlarged issued capital.
Harworth Group plc (HWG) · 2026-09-15
Harworth is targeting at least £7.4 million of annualised cost savings by the financial year ending 31 December 2028, equivalent to a 20.4% reduction in administrative expenses. The programme has already delivered £1.3 million but requires £3.85 million of one-off implementation costs.
M&C Saatchi PLC (SAA) · 2026-09-15
M&C Saatchi has completed its share buyback programme after purchasing a final 27,500 ordinary shares at 144.00 pence each. The programme repurchased 2,222,500 shares for £2,877,594 in total, and is due to terminate on 15 September 2026.
Sunbelt Rentals Holdings, Inc. (SUNB) · 2026-09-15
Sunbelt Rentals repurchased 36,000 common shares between 8 and 11 September 2026 under its $1.5 billion share repurchase programme. The shares are intended to be held in treasury.
ImmuPharma PLC (IMM) · 2026-09-15
ImmuPharma has published peer-reviewed preclinical research showing P140 reduced steatohepatitis and fibrosis in an established mouse model of advanced metabolic dysfunction-associated steatohepatitis. The findings add biological evidence beyond P140's original lupus setting, but remain preclinical.
Thor Explorations Ltd. (THX) · 2026-09-15
Maiden drilling at Marahui returned gold intersections including 9m at 5.40 g/t Au from 40m, as Thor completed 18,439m of its 25,000m reverse circulation programme. Drilling has tested approximately 30% of the geological trend, with further assays pending.
ImmuPharma PLC (IMM) · 2026-09-15
ImmuPharma has filed an international patent application for its P140 precision medicine approach in autoimmune disease, covering identification and treatment of patients with the Type M immune profile. The application now enters international search and publication, while commercial partnering discussions continue towards a 2026 deal.
Chief Financial Officer Stephen Pinkerton intends to retire after ten years with hVIVO and will remain until 30 September 2026. Non-Executive Director Richard Cotton will become interim CFO while the Board completes its permanent successor search.
Cairn Homes plc (CRN) · 2026-09-15
Cairn Homes purchased 100,000 ordinary shares on Euronext Dublin and 50,000 on the London Stock Exchange. Following settlement and cancellation, 627,773,467 ordinary shares will remain in issue.
Burford Capital Limited (BUR) · 2026-09-15
Burford has priced a $300 million private offering of 8.000% senior secured notes due 2029. Net proceeds and cash on hand are intended to redeem its 6.250% senior notes due 2028 after closing, which remains subject to customary conditions.
Symphony Environmental Technologies Plc (SYM) · 2026-09-15
Symphony Environmental Technologies' d2p® EA active packaging cut ethylene concentrations by 16.8%–46.7% across six test conditions, versus 0.8%–4.0% for conventional polyethylene packaging. The company has also delivered its first commercial container-load to Sirane Central Americana in Mexico.
Kazera Global plc (KZG) · 2026-09-15
Kazera Global has secured a binding £221,962.44 additional subscription, lifting planned gross fundraising to approximately £722,000, subject to shareholder approval. Angola partnership discussions remain early-stage.
First Development Resources plc (FDR) · 2026-09-15
Initial drilling at Lander West returned gold at Red Handed and a separate copper intersection, supporting further exploration targets. Drillhole 26LWR08 intersected 7m @ 0.40 g/t Au from 50m downhole, while 26LWR02 returned 8m @ 0.32% Cu from 47m downhole.
Imaging Biometrics Limited (IBAI) · 2026-09-15
Imaging Biometrics' US subsidiary has secured an annual subscription agreement with a leading health system for its quantitative brain tumour imaging software. The installation is the second major new installation this quarter, extending adoption of the platform.
Pri0r1ty Intelligence Group PLC (PR1) · 2026-09-15
Halfspace renewed Premier League match-day sales support for 2026-27, adding a three-month Vox trial alongside £30k per annum SaaS and approximately £40k annual consultancy fees.
Alternative Income REIT plc (AIRE) · 2026-09-15
Glenstone's 70 pence in cash per AIRE Share offer for Alternative Income REIT is unconditional, with holdings and valid acceptances representing approximately 61.05% of shares. Further acceptances could trigger a London listing cancellation at 75% or compulsory acquisition at 90%.
Haydale Graphene Industries PLC (HAYD) · 2026-09-15
Haydale's SETTF thermal-fluid product is moving towards commercial deployment, with advanced discussions covering approximately 200 MW of data-centre capacity and a first installation targeted within twelve months. The proposed commercialisation venture is intended to use dedicated external capital.
Kistos Holdings PLC (KIST) · 2026-09-15
Kistos has completed its acquisition of Blocks 3 & 4 from Mitsui after legal ownership transferred. The linked Block 9 acquisition remains expected to complete in H2 2026.
Marketing Director Sarah Kingsbury will step down from the board on 14 September 2026 as Distil shifts certain brand, marketing and commercial activities to Fortitude Spirits Group under its proposed operating model.
Clontarf Energy plc (CLON) · 2026-09-15
Clontarf Energy's loss widened to (256) from (245) for the six months ended 30 June 2026, while cash and cash equivalents fell to 248 from 375. Its Bolivia joint venture remains pre-licence, without extraction rights or commercial operations.
GSK has agreed to acquire global rights to a trispecific T cell-engager for multiple myeloma, expanding its blood-cancer pipeline. The programme is expected to enter phase I trials in 2027, while the deal's potential value is up to $750 million.
Alternative Income REIT PLC (AIRE) · 2026-09-15
Simon Bennett has resigned as Chair and a Non-Executive Director with immediate effect. Stephanie Eastment will serve as Independent Non-Executive Chair on a short-term interim basis, while Adam Smith has been re-appointed as a Non-Executive Director.